Catalyst Wire Dossier Catalyst Wire Dossier

Allocetra-OTS

· Enlivex Therapeutics Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Allocetra-OTS, covering 2020-10-22 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety [EARLY_Phase 1]

See pricing